Image

Global Lyophilized Injectable Drugs Market – Industry Trends and Forecast to 2031

Pharmaceutical

Image

Global Lyophilized Injectable Drugs Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Lyophilized Injectable Drugs Market, By Packaging (Vials, Dual-Chamber Syringes, Dual-Chamber Cartridges, Specialty Packaging, Point-Of-Care Reconstitution, Single-Use Vials, and Others),Type of Delivery (Single-Step Devices, Multi-Step Devices, Prefilled Diluent Syringes, and Proprietary Reconstitution Devices), Drug Class (Anti-Infective, Antineoplastic, Diuretics, Proton Pump Inhibitor, Anesthetic, Anticoagulant, NSAID’s, Corticosteroids and Others), Form (Powder and Liquid), Indication (Oncology, Autoimmune Diseases, Hormonal Disorders, Metabolic Conditions, Respiratory Diseases, Gastrointestinal Disorders, Dermatological Disorders, Ophthalmic Diseases, Infectious Diseases, and  Others), Route of Administration (Intravenous/Infusion, Intramuscular and Others), End User (Hospital, Clinics,  Ambulatory Surgery Centers (ASCs), Home Healthcare and  Others), Distribution Channel (Direct Tender, Retail Sales and Others) – Industry Trends and Forecast to 2031.

 Lyophilized Injectable Drugs Market

Lyophilized Injectable Drugs Market Analysis and Size

Lyophilized injectable drugs are vital in treating diverse medical conditions such as infections, cancer, and autoimmune diseases. They provide convenient and effective treatment options globally, especially for patients with chronic ailments, ensuring reliable access to essential medications for managing their health effectively.                           

Data Bridge Market Research analyses that the global lyophilized injectable drugs market, which was USD 3,196.39 million in 2023, is expected to reach USD 5,171.96 million by 2031, and is expected to undergo a CAGR of 6.2% during the forecast period of 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Lyophilized Injectable Drugs Market Scope and Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Packaging (Vials, Dual-Chamber Syringes, Dual-Chamber Cartridges, Specialty Packaging, Point-Of-Care Reconstitution, Single-Use Vials, and Others),Type of Delivery (Single-Step Devices, Multi-Step Devices, Prefilled Diluent Syringes, and Proprietary Reconstitution Devices), Drug Class (Anti-Infective, Antineoplastic, Diuretics, Proton Pump Inhibitor, Anesthetic, Anticoagulant, NSAID’s, Corticosteroids and Others), Form (Powder and Liquid), Indication (Oncology, Autoimmune Diseases, Hormonal Disorders, Metabolic Conditions, Respiratory Diseases, Gastrointestinal Disorders, Dermatological Disorders, Ophthalmic Diseases, Infectious Diseases, and  Others), Route of Administration (Intravenous/Infusion, Intramuscular and Others), End User (Hospital, Clinics,  Ambulatory Surgery Centers (ASCs), Home Healthcare and  Others), Distribution Channel (Direct Tender, Retail Sales and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Affy Pharma Pvt Ltd. (India), GENEX PHARMA (India), Aurobindo Pharma USA (U.S.), Astellas Pharma Inc. (U.S.), Pfizer Inc. (U.S.), Viatris Inc. (U.S.), Gilead Sciences, Inc. (U.S.), Cirondrugs (India), Amneal Pharmaceuticals LLC (U.S.), Jubilant Generics Limited (India), Novartis AG (Switzerland), Otsuka America Pharmaceutical, Inc. (U.S.), Zydus Group (India), Cipla Inc. (India), Merck & Co., Inc. (Germany), Fresenius Kabi AG (U.S.), Sanofi (France), CELON LABS (India) and Baxter (U.S.)

Market Opportunities

  • Expanding Healthcare Infrastructure Enhance Accessibility
  • Personalized Medicine for Better Therapeutic Outcomes

Market Definition

Lyophilized injectable drugs are pharmaceutical products that undergo freeze-drying to remove water from their formulations, resulting in a stable, solid state. This process enables long-term storage and enhances drug stability, particularly important for sensitive biologics and vaccines, which can be reconstituted with a solvent before administration.            

Global Lyophilized Injectable Drugs Market Dynamics

Drivers

  • Global Pandemic Preparedness by Vaccine Preservation

The COVID-19 pandemic has heightened attention on lyophilized drugs for their role in vaccine development and storage. Their stability and extended shelf life make them vital tools for ensuring global health preparedness, offering solutions for vaccine preservation and distribution during crises, underscoring their importance in pandemic response strategies and vaccine supply chain management.

  • Increasing Geriatric Population with Chronic Illness

The growing elderly demographic, susceptible to chronic illnesses, drives demand for lyophilized injectable drugs, prized for their reliability and effectiveness in treatment. As this population segment expands, there is a heightened need for pharmaceutical solutions that offer enhanced stability and convenience, aligning with the requirements of aging patients and healthcare providers.

Opportunities

  • Expanding Healthcare Infrastructure Enhance Accessibility

Investments in healthcare infrastructure in developing regions create opportunities for expanding the market for lyophilized drugs. Improved healthcare facilities and distribution networks enhance accessibility to these medications, addressing unmet medical needs and driving market growth. This trend reflects a growing commitment to healthcare advancement and improved patient care in emerging economies.

  • Personalized Medicine for Better Therapeutic Outcomes

Advancements in precision medicine and targeted therapies are fueling the demand for customized lyophilized formulations in personalized medicine. Tailored to individual patient needs and treatment efficacy, these formulations offer precise dosing and delivery, optimizing therapeutic outcomes. This trend reflects the growing importance of personalized approaches in modern healthcare. 

Restraints/Challenges

  • Packaging Issues Impacting Product Quality

Preserving product integrity in lyophilized injectable drugs involves designing containers that withstand freeze-drying and maintain stability post-lyophilization. Achieving compatibility between packaging materials and drugs is complex, impacting quality, safety, and regulatory compliance. Packaging challenges pose a significant hurdle in the market. 

  • High Production Costs Limit Affordability

High production costs associated with lyophilization hinder market accessibility by inflating drug pricing. These elevated expenses, stemming from specialized equipment and expertise needed for the process, limit affordability for patients and healthcare systems. Consequently, accessibility to lyophilized drugs becomes restricted, hindering their widespread adoption and potentially impeding market growth. 

This global lyophilized injectable drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global lyophilized injectable drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In November 2022, Telstar expanded its process laboratory service for freeze-drying and sterilization, incorporating cold sterilization methods for non-compatible medical and pharmaceutical products alongside conventional high-temperature sterilization, enhancing its offerings and capabilities in the industry
  • In March 2021, Zydus Cadila reduced the cost of its drug Remdac, a generic version of Remdesivir used for COVID-19 patients in India. This strategic move bolstered demand and sales, elevating the company's credibility in the market
  • In August 2020, Jubilant Pharma Limited launched JUBI-R, Remdesivir for injection, amidst the COVID-19 pandemic. This timely introduction enhanced the company's reputation and market demand, displaying its responsiveness to critical healthcare needs
  • In July 2020, Fondaco Pte Ltd recalled its product euronox Lyophilized Powder for Injection 100 units/vial due to potential quality issues, impacting its credibility and market demand negatively, underscoring the importance of product quality control and assurance measures

Global Lyophilized Injectable Drugs Market Scope

The global lyophilized injectable drugs market is segmented on the basis of packaging, type of delivery, drug class, form, indication, route of administration, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Packaging

  • Vials
  • Dual-Chamber Syringes
  • Dual-Chamber Cartridges
  • Specialty Packaging
  • Point-Of-Care Reconstitution
  • Single-Use Vials
  • Others

Type of Delivery

  • Single-Step Devices
  • Multi-Step Devices
  • Prefilled Diluent Syringes
  • Proprietary Reconstitution Devices

 Drug Class

  • Anti-Infective
  • Antineoplastic
  • Diuretics
  • Proton Pump Inhibitor
  • Anesthetic
  • Anticoagulant
  • NSAID’s
  • Corticosteroids
  • Others

 Form

  • Powder
  • Liquid

 Indication

  • Oncology
  • Autoimmune Diseases
  • Hormonal Disorders
  • Metabolic Conditions
  • Respiratory Diseases
  • Gastrointestinal Disorders
  • Dermatological Disorders
  • Ophthalmic Diseases
  • Infectious Diseases
  • Others

 Route of Administration

  • Intravenous/Infusion
  • Intramuscular
  • Others

End User

  • Hospital
  • Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Home Healthcare
  • Others

 Distribution Channel

  • Direct Tender
  • Retail Sales
  • Others

Global Lyophilized Injectable Drugs Market Regional Analysis/Insights

The global lyophilized injectable drugs market is analysed and market size insights and trends are provided by country, packaging, type of delivery, drug class, form, indication, route of administration, end user and distribution channel as referenced above.

The countries covered in the global lyophilized injectable drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to witness high growth in the lyophilized injectable drugs market, particularly in the U.S. The vials segment is projected to dominate, benefiting from lower prices compared to other packing materials, supported by major market players and technological advancements in the region.

Asia-Pacific is expected to dominate the lyophilized injectable drugs market due to rising demand for these medications to treat various diseases. Japan, in particular, is emerging as a key player in the region, driven by increasing demand for lyophilized drugs across therapeutic areas.

Europe is expected to dominate in the lyophilized injectable drugs market, with the vials segment leading in Germany. The region's dominance is attributed to the rising number of research and development laboratories for drug testing, particularly in Germany, fostering demand for lyophilized injectable drugs packaged in vials.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The global lyophilized injectable drugs market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global lyophilized injectable drugs market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global lyophilized injectable drugs market. The data is available for historic period 2016-2021.

Competitive Landscape and Global Lyophilized Injectable Drugs Market Share Analysis

The global lyophilized injectable drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global lyophilized injectable drugs market.

Some of the major players operating in the global lyophilized injectable drugs market are:

  • Affy Pharma Pvt Ltd. (India)
  •  GENEX PHARMA (India)
  •  Aurobindo Pharma USA (U.S.)
  •  Astellas Pharma Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  •  Viatris Inc. (U.S.)
  •  Gilead Sciences, Inc. (U.S.)
  •  Cirondrugs (India)
  •  Amneal Pharmaceuticals LLC (U.S.)
  •  Jubilant Generics Limited (India)
  •  Novartis AG (Switzerland)
  •  Otsuka America Pharmaceutical, Inc. (U.S.)
  •  Zydus Group (India)
  •  Cipla Inc. (India)
  •  Merck & Co., Inc. (Germany)
  •  Fresenius Kabi AG (U.S.)
  • Sanofi (France)
  •  CELON LABS (India)
  • Baxter (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The lyophilized injectable drugs market size will be worth USD 5,171.96 million by 2031.
The growth rate of the lyophilized injectable drugs market is 6.2% by 2031.
Global pandemic preparedness by vaccine preservation & increasing geriatric population with chronic illness are the growth drivers of the lyophilized injectable drugs market.
Packaging, type of delivery, drug class, form, indication, route of administration, end user and distribution channel are the factors on which the lyophilized injectable drugs market research is based.
Major companies in the lyophilized injectable drugs market are Affy Pharma Pvt Ltd. (India), GENEX PHARMA (India), Aurobindo Pharma USA (U.S.), Astellas Pharma Inc. (U.S.), Pfizer Inc. (U.S.), Viatris Inc. (U.S.), Gilead Sciences, Inc. (U.S.), Cirondrugs (India), Amneal Pharmaceuticals LLC (U.S.), Jubilant Generics Limited (India), Novartis AG (Switzerland), Otsuka America Pharmaceutical, Inc. (U.S.), Zydus Group (India), Cipla Inc. (India), Merck & Co., Inc. (Germany), Fresenius Kabi AG (U.S.), Sanofi (France), CELON LABS (India) and Baxter (U.S.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials